News > Living Beyond Breast Cancer releases updated needs assessment of young women diagnosed with breast cancer

Living Beyond Breast Cancer releases updated needs assessment of young women diagnosed with breast cancer

2020 national survey provides a long-term look at issues first assessed 8 years ago and shows progress, areas for improvement, and new areas of unique need in caring for young women diagnosed with breast cancer


Arin Ahlum Hanson, MPH, Living Beyond Breast Cancer’s director of outreach, says LBBC will use these findings to improve existing programs and develop new ones that support young women throughout their breast cancer experience. "Continuing our long-term commitment to providing young women with tailored services and support, we developed the 2020 needs assessment to analyze young women’s changing preferences and information needs to refine our programming for future generations," she added.



Most people diagnosed with breast cancer are diagnosed after age 50. Yet a rising number of young women living in the United States are diagnosed with breast cancer each year.

Being young at diagnosis introduces many unique experiences and social and emotional needs, often because of life stage: younger people are more likely to be at the beginnings of their career, still in school, dating, or having children. In 2012, Living Beyond Breast Cancer conducted a national needs assessment to look at the unique needs of young women diagnosed with breast cancer, as well as how they preferred to receive emotional support and breast cancer information compared to women diagnosed at older ages. The findings of the 2012 assessment guided LBBC’s development of programs within the Young Women’s Initiative.

The 2020 follow-up survey assesses progress made on areas of need identified in 2012 and explores whether and how information and support preferences have changed. Both the 2012 and 2020 needs assessments were conducted through LBBC’s Young Women’s Initiative, a program funded through a cooperative agreement with the U.S. Centers for Disease Control and Prevention.

"We wanted to take an intentional look at how demographic differences impact the breast cancer experience for women diagnosed before age 45," Ms. Hanson says.



A total of 717 people diagnosed before the age of 45 responded to an 88-question online survey developed by LBBC. Participants did not need to be under age 45 at the time of the survey. Respondents were diagnosed with any stage and subtype of breast cancer, including metastatic breast cancer.

The survey asked detailed questions about treatment side effects, communication with healthcare providers, and how participants sought emotional support and breast cancer information. Several questions emphasized whether and how the participants felt their sexual, physical, and emotional health needs were met throughout their treatment and care. LBBC analyzed the data by race and ethnicity, cancer stage, age at diagnosis, and the length of time passed since diagnosis to look for any significant differences between these groups.


We wanted to take an intentional look at how demographic differences impact the breast cancer experience for women diagnosed before age 45. It’s important to be able to take deliberate action on demographic differences in order to give people the support they need and meet them where they are.

Janine E. Guglielmino, MA


The majority (72.4 percent) of respondents were Caucasian, followed by 14.2 percent Black or African American, and 5.6 percent Hispanic. Due to the low recruitment of people of other ethnicities, the findings only reflect Caucasian, Black, and Hispanic participant responses and may not be easily applied to other ethnic group experiences.



Overall, the 2020 needs assessment found that breast cancer diagnosis and its treatment causes significant physical and emotional impacts on women diagnosed before age 45, and that a woman’s race and ethnicity, cancer stage, and how much time has passed since diagnosis lead to differences in how women experience those physical and emotional impacts.

Sexual health and fertility

Many participants reported diagnosis and treatment had a significant impact on their sexual health, yet most reported that their healthcare provider was unable to help address sexual health needs. Likewise, this assessment found virtually no improvement in the likelihood of healthcare providers discussing the impact of treatments on future fertility: The percentage of young women reporting discussions about fertility with their healthcare providers and the percentage reporting they initiated the conversation themselves remain relatively unchanged from 2012 to 2020.

Genetic testing and counseling

The 2020 assessment showed improvement in the number of young women receiving genetic counseling alongside genetic testing. While only half of the 2012 respondents who reported getting genetic testing reported speaking with a genetic counselor, nearly 73 percent of 2020 respondents who had testing reported speaking with a counselor. Still, the 2020 data shows disparities in both testing and counseling based on race and ethnicity.

Emotional support and breast cancer information preferences

While the 2012 cohort overwhelmingly reported not knowing where to find information and support targeted to young women diagnosed with breast cancer, the 2020 needs assessment found that most young women knew where to find targeted resources adequate to their needs. A woman’s race and ethnicity, and cancer stage, impacted how she preferred to access breast cancer information and emotional support.

More Black women felt it very important to connect with women who shared their ethnic background than did participants of other ethnic backgrounds. More Black and Hispanic women also reported feeling it very important to connect with women who shared their diagnosis than did participants from other ethnic groups.

In terms of cancer stage, women diagnosed with DCIS were most likely to prefer social media for emotional support and connection, while young women living with metastatic breast cancer rated all types of emotional support services highly, with a lower interest in in-person support.



The 2020 national needs assessment of young women diagnosed with breast cancer revealed that while some aspects of the breast cancer experience have improved for women diagnosed before age 45, there remain a number of gaps in their care and survivorship needs. These gaps are even more pronounced when demographics such as race and ethnicity are considered. Living Beyond Breast Cancer, healthcare providers serving young women with breast cancer, and other advocacy organizations should consider these findings when developing future programs and trainings.


Related articles

Early menopause

08/26/22 | BY: Ann Honebrink

If you are premenopausal or perimenopausal, breast cancer treatments — including surgery to remove ovaries, chemotherapy, and hormonal therapy — may cause your menstrual periods to stop for a while or, in some cases, permanently.

Read More | 9 Min. Read |

Young Women

05/04/22 | BY: Don S. Dizon

If you’re a woman diagnosed with breast cancer before the age of 45, your medical and emotional concerns may be very different than those of women who are diagnosed when they are older. Body image, relationships, career, intimacy, fertility, and parenting are just some of the issues and life areas that can bring up questions for you.

Read More |

Healthcare providers

08/19/20 | BY: LBBC Staff

LBBC can help healthcare providers strengthen relationships with patients and improve their satisfaction. Our trusted, expert-reviewed resources can offer a greater depth of knowledge and understanding for your patients. Sharing our resources not only enhances the quality of care healthcare providers are able to administer but also saves time.

Ovarian suppression


Ovarian suppression is surgery, radiation therapy or medicine that is used in premenopausal women to stop the ovaries from working.

Read More | 4 Min. Read

Gonadotropin releasing hormone (GnRH) agonists

10/07/19 | BY: H. Irene Su

The gonadotropin releasing hormone agonists, or GnRH agonists, are a class of injectable medicines offered to pre- and perimenopausal women with breast cancer in order to temporarily suppress, or slow, ovarian function.

Read More | 5 Min. Read

Making decisions about protecting your fertility

09/06/19 | BY: H. Irene Su

You might not be thinking about having a family at the time of your diagnosis, but that’s the best time to talk with your partner, family, and healthcare team about future fertility.

Read More | 6 Min. Read

Protecting your fertility during treatment

08/06/19 | BY: H. Irene Su

If you are premenopausal (still having menstrual periods), breast cancer treatments such as chemotherapy and hormonal therapy can affect your fertility. This may make it harder to become pregnant after treatment ends.

Read More | 6 Min. Read

Birth control and breast cancer

08/05/19 | BY: H. Irene Su

If you were not in menopause before your breast cancer diagnosis and you are sexually active, it’s important to discuss birth control, or contraception, with your doctor. During treatment, you should not become pregnant. Early in pregnancy, chemotherapy and hormonal therapy can harm a fetus and lead to birth defects.

Read More | 5 Min. Read

Am I in menopause

08/05/19 | BY: H. Irene Su

Women affected by breast cancer may be premenopausal or perimenopausal before diagnosis. Learn more about early menopause, and other ways that you may be affected.

Read More | 5 Min. Read

Fertility treatment options

08/01/19 | BY: Kristin Smith

A breast cancer diagnosis can force you to think about the future sooner than you expect. We can help you learn about options to preserve fertility. Use our chart as a starting point to talk with your healthcare provider about what is important to you for your future.